# Mirum Pharmaceuticals, Inc. (MIRM) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Mirum Pharmaceuticals, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/MIRM/mda/fy2025/): filed 2026-02-25; accession 0001759425-26-000013 (https://www.sec.gov/Archives/edgar/data/1759425/000175942526000013/mirm-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/MIRM/mda/fy2024/): filed 2025-02-26; accession 0001759425-25-000014 (https://www.sec.gov/Archives/edgar/data/1759425/000175942525000014/mirm-20241231.htm)
- [FY 2023 MD&A](/company/MIRM/mda/fy2023/): filed 2024-03-15; accession 0000950170-24-032289 (https://www.sec.gov/Archives/edgar/data/1759425/000095017024032289/mirm-20231231.htm)
- [FY 2022 MD&A](/company/MIRM/mda/fy2022/): filed 2023-03-08; accession 0000950170-23-006715 (https://www.sec.gov/Archives/edgar/data/1759425/000095017023006715/mirm-20221231.htm)
- [FY 2021 MD&A](/company/MIRM/mda/fy2021/): filed 2022-03-09; accession 0000950170-22-003229 (https://www.sec.gov/Archives/edgar/data/1759425/000095017022003229/mirm-20211231.htm)

Back to /company/MIRM/